Update: China Biologic Acquires Additional Interest In Guizhou Facility - Shares Rise
Trevor Lowenthal • Tue, Aug. 26
- China Biologic acquires additional equity in the Guizhou Taibang Facility.
- Since this will likely lead to earnings accretion, I reiterate my bull thesis on China Biologic.
- This event came as a surprise, since I anticipated that funds from the latest offering would be used to offset rising operating expenses, not to fund a strategic acquisition.